Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: SOBI Announces Revised Full Year Outlook And Advances Publication Of The Q3 2025 Financial Report

Oct 19 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

SOBI ANNOUNCES REVISED FULL YEAR OUTLOOK AND ADVANCES PUBLICATION OF THE Q3 2025 FINANCIAL REPORT

SOBI Q3 REVENUE SEK 7,776 MILLION VS. IBES ESTIMATE SEK 7,907 MILLION

ADJUSTED EBITA MARGIN FOR Q3 2025 WAS 47 PER CENT

SOBI RECORDS SEK 6,612 M IMPAIRMENT CHARGE IN Q3 2025 FOR VONJO

REVISED FULL YEAR OUTLOOK FOR 2025, REVENUE IS NOW ANTICIPATED TO GROW BY A LOW DOUBLE-DIGIT PERCENTAGE AT CER

2025 ADJUSTED EBITA MARGIN IS ANTICIPATED TO BE IN MID-TO-HIGH 30'S PER CENT OF REVENUE

Source text: ID:nWkr6fBSnk

Further company coverage: SOBIV.ST

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Swedish Orphan Biovitrum AB (publ)

See all news